News | Science Selection Nov-Dec 2013 | Volume 121 | Issue 11-12
Toxicity Testing from the Bottom Up: Proposed Protocol for Screening Pollutants Linked to Insulin Resistance
Carol Potera, based in Montana, has written for EHP since 1996. She also writes for Microbe, Genetic Engineering News, and the American Journal of Nursing.
Citation: Potera C. 2013. Toxicity testing from the bottom up: proposed protocol for screening pollutants linked to insulin resistance. Environ Health Perspect 121:A343; http://dx.doi.org/10.1289/ehp.121-A343
Published: 1 December 2013
Related EHP Article
Impaired insulin resistance (IR) is a precursor of type 2 diabetes, which is on the rise. A review of 23 studies in this issue of EHP investigates the effects of exposure to pollutants on IR.1 Based on methods described in the 23 papers, the researchers constructed a four-level protocol for IR toxicity testing, a streamlined scheme that offers a starting point for future IR–pollutant research.
The investigators modeled their plan after a conceptual framework proposed by the Organisation for Economic Co-operation and Development for evaluating endocrine-disrupting chemicals.2 Included among the larger family of endocrine disruptors are “metabolic disruptors,” which perturb metabolic signaling and contribute to diabetes, obesity, and other metabolic disorders.3
Most of the studies reviewed used a “top-down” experimental design, meaning they first looked for outcomes in whole animals and then assessed effects at lower levels of biological organization—molecules, cells, tissues, and organs. The review authors point to the need for more “bottom-up” experiments that focus on molecular events that precede IR development. Once investigators identify potential inducers of IR, they can assess higher-level effects of these pollutants.
A uniform bottom-up testing scheme could lower costs, save time, and reduce the number of laboratory animals needed to identify IR-inducing pollutants.1 “We need to look for molecular targets and cellular events underlying IR and use this information to build an array of assays to efficiently screen thousands of pollutants without having to sacrifice a lot of animals,” says lead author Tine Hectors, a toxicologist at the University of Antwerp, Belgium, at the time of the research (she is now at the University of California, Irvine).
Level 1 of the proposed scheme covers mechanistic information, such as gene and protein expression or insulin signaling pathway data. Level 2 includes tissue and cellular assays, such as measuring insulin-stimulated glucose uptake in cells known as primary adipocytes. More in-depth studies in key organs, such as monitoring insulin sensitivity in skeletal muscle, form Level 3. And whole-animal testing of pollutants falls into Level 4.1
© Jim Dowdalls/Science Source
The goal of bottom-up testing is to identify potential metabolic disruptors that deserve more in-depth testing in animals, similar to screens for carcinogens and mutagens. Hectors suggests that this bottom-up screening approach could be used to identify potentially harmful metabolic disruptors that warrant further scrutiny by regulatory agencies. Analysis of molecular targets of metabolic disruptors also may reveal new drug targets to treat IR.
However, Hectors cautions that pollutant-induced IR is still a very new area of toxicology. “We are very far away from developing prevention and intervention strategies,” she says.
“Metabolic disruptors are an emerging concept that is gaining increasing attention, and Hectors’ paper offers a thorough review of the state of the science linking metabolic disruptors with insulin resistance and diabetes,” says Bruce Blumberg, a professor of developmental and cell biology at the University of California, Irvine, who was not involved in the review. Hectors and colleagues not only highlight the strengths and weaknesses of current screening assays but also suggest future in vitro assays that could accurately capture metabolic end points, Blumberg says.
Nearly all people with type 2 diabetes have IR.4 In 2010 an estimated 25.6 million U.S. residents over age 20 had diagnosed or undiagnosed diabetes, and the direct and indirect costs of diabetes in the United States reached $174 billion in 2007.5 Worldwide, the prevalence of diabetes doubled between 1980 and 2008.6
IR is involved not only in diabetes, but also obesity, metabolic syndrome, liver disease, and heart disease.7 A better understanding of the molecular and cellular events underlying IR could apply to these related disorders as well, or help to guide health and economic policy.
1. Hectors TLM, et al. Insulin resistance and environmental pollutants: experimental evidence and future perspectives. Environ Health Perspect 121(11–12):1273–1281 (2013); http://dx.doi.org/10.1289/ehp.1307082.
2. OECD. Guidance Document on Standardized Test Guidelines for Evaluating Chemicals for Endocrine Disruption. Series on Testing and Assessment, No. 150. Paris, France:Organisation for Economic Co-operation and Development (2012). Available: http://goo.gl/JlINU5 [accessed 25 October 2013].
3. Casals-Casas C, et al. Interference of pollutants with PPARs: endocrine disruption meets metabolism. Int J Obes 32(suppl 6):S53–S61 (2008); http://dx.doi.org/10.1038/ijo.2008.207.
4. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88(4):787–835 (2004); http://dx.doi.org/10.1016/j.mcna.2004.04.013.
5. CDC. 2011 National Diabetes Fact Sheet [website]. Atlanta, GA:U.S. Centers for Disease Control and Prevention (updated 23 May 2011). Available: http://www.cdc.gov/diabetes/pubs/estimates11.htm [accessed 25 October 2013].
6. Danaei G, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785):31–40 (2011); http://dx.doi.org/10.1016/S0140-6736(11)60679-X.
7. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell 148(5):852–871 (2012); http://dx.doi.org/10.1016/j.cell.2012.02.017.
If you’re attending the American Public Health Association (APHA) 2016 Annual Meeting and Expo in Denver (October 30–November 2), stop by the NIEHS booth (#1214) in the Exhibition Hall. Children’s Health Editor Martha M. Dimes will be available to discuss EHP submissions, Children’s Health topics, and more.
EHP is pleased to launch its new Children’s Health page. This dynamic page will feature timely children’s health research and news as they are published in EHP as well as links to related material. The page includes its own “Search Children’s Health” function so visitors can search our full library of children’s health content by topic, author, or publication year and find exactly the information they need. Bookmark the page or access it via the “Featured Children’s Health” section on EHP’s home page. (more…)
EHP is proud to announce that “Polychlorinated Biphenyl and Organochlorine Pesticide Concentrations in Maternal Mid-Pregnancy Serum Samples: Association with Autism Spectrum Disorder and Intellectual Disability,” published in EHP on 23 August 2016, has been selected by the Children’s Environmental Health Network (CEHN) as its October 2016 Article of the Month. CEHN Article of the Month summaries discuss the potential policy implications of current children’s environmental health research. The CEHN summary can be viewed here.
Featured Children’s Health
Veronica A. Tinney, Jerad M. Denton, Lucy Sciallo-Tyler, and Jerome A. Paulson
Jerome A. Paulson and Claire L. Barnett
Kim G. Harley, Katherine Kogut, Daniel S. Madrigal, Maritza Cardenas, Irene A. Vera, Gonzalo Meza-Alfaro, Jianwen She, Qi Gavin, Rana Zahedi, Asa Bradman, Brenda Eskenazi, and Kimberly L. Parra
Rebecca Massa Nachman, Guangyun Mao, Xingyou Zhang, Xiumei Hong, Zhu Chen, Claire Sampankanpanich Soria, Huan He, Guoying Wang, Deanna Caruso, Colleen Pearson, Shyam Biswal, Barry Zuckerman, Marsha Wills-Karp, and Xiaobin Wang